News

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
Diane Brady talks to Pfizer CEO Albert Bourla about defending science amid a backdrop of political threats. The big story: ...
Reviewing PFE’s five-year history, the stock has experienced a balanced 50-50 distribution of positive and negative returns ...
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.
Pfizer has been paying dividends for 35 years and raising them for 14 years. Read more to see whether PFE stock is a buy.
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...
Fewer jobs in US steel mills and assembly lines didn’t mean the end of US manufacturing. Nor did it mean the end of US ...
Nearly a year and a half after Covid vaccines became available to adults in the U.S., the FDA has authorized two vaccines for ...
Which stocks trading for less than $30 per share are worth investing in today? Let's consider two great options: Pfizer ( PFE ...
Last week, Pfizer announced that it would no longer develop danuglipron, a daily GLP-1 weight-loss drug which investors were ...
Pharmaceutical and biotechnology company Pfizer marks 70 years of dedication to its mission of advancing patient health in ...